Eli Lilly announces Phase 3 ATTAIN-2 trial results for oral GLP-1 agonist orforglipron in obesity and type 2 diabetes Read more
Novartis and BioArctic sign collaboration agreement on BrainTransporter technology for neurological drug development Read more
Industry expert calls for GST parity to support MSMEs and strengthen India’s position as the ‘Pharmacy of the World’ Read more
Akums and Government of Zambia form joint venture to establish pharma manufacturing facility Read more
Zydus Lifesciences hosts health symposium on new WHO influenza vaccination guideline for Northern Hemisphere 2025-26 Read more